Catyalyst Pharma (CPRX) Reports In-Line Q4 EPS
Tweet
Share
E-mailGet Alerts CPRX Hot Sheet
Price: $31.49 --0%
Financial Fact:
Research and development: 2.49M
Today's EPS Names:
LUNA, BTTX, VAXX, More
Financial Fact:
Research and development: 2.49M
Today's EPS Names:
LUNA, BTTX, VAXX, More
Join SI Premium – FREE
Catyalyst Pharma (NASDAQ: CPRX) reported Q4 EPS of ($0.07), in-line with the analyst estimate of ($0.07).
For earnings history and earnings-related data on Catyalyst Pharma (CPRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development
- Morgan Stanley Starts Target Hospitality (TH) at Overweight
- Genco rejects Diana Shipping bid, calls offer below NAV
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
